Keywords monoclonal antibody

Remission of severe forms of long COVID following monoclonal antibody (MCA) infusions: A report of signal index cases and call for targeted research (NEW 1/18, Website)

ScienceDirect

4 October 2023

Scheppke KA, Pepe PE, et al.
Three individuals with long Covid experienced full remission within a week after monoclonal antibody infusion.

keywords: covid-19, Long COVID, MAB, monoclonal antibody

Important Updates on COVID-19 Therapeutics for Treatment and Prevention (Website, Regulatory)

CDC HAN

20 December 2022

The majority of Omicron sublineages circulating in the United States have reduced susceptibility to the monoclonal antibody, bebtelovimab and the monoclonal antibody combination, cilgavimab and tixagevimab (EvusheldTM). Antiviral therapeutics for the treatment of COVID-19, ritonavir-boosted nirmatrelvir (Paxlovid™), remdesivir (Veklury®), and molnupiravir (Lagevrio™), retain activity against currently circulating Omicron sublineages.

keywords: covid-19, monoclonal antibody, paxlovid

Coronavirus (COVID-19) Update: FDA Authorizes New Monoclonal Antibody for Treatment of COVID-19 that Retains Activity Against Omicron Variant (NEW 3/7, Website, Regulatory)

FDA

11 February 2022

keywords: covid-19, monoclonal antibody, treatment

Using Therapeutics to Prevent and Treat COVID-19 (NEW 12/5, Website, Regulatory)

CDC / Health Alert Network

Good summary of vaccine information (elegibility, ages, boosters, side effects, safety, etc.).

keywords: antivirals, covid-19, monoclonal antibody, treatment

Resources with keywords: monoclonal antibody